Pan-cancer profiling of the effect of biopsied site on tumor mutational burden measurements in a real-world data cohort

被引：0
|
作者：
Papillon-Cavanagh, Simon [1 ]
Gao, Chuan [1 ]
Han, G. Celine [1 ]
Walsh, Alice M. [1 ]
机构：
[1] Bristol Myers Squibb, Princeton, NJ USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-2008
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2008
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Pan-cancer analysis of the effect of biopsy site on tumor mutational burden observations
    Papillon-Cavanagh, Simon
    Hopkins, Julia F.
    Ramkissoon, Shakti H.
    Albacker, Lee A.
    Walsh, Alice M.
    COMMUNICATIONS MEDICINE, 2021, 1 (01):
  • [2] Pan-cancer analysis of the effect of biopsy site on tumor mutational burden observations
    Simon Papillon-Cavanagh
    Julia F. Hopkins
    Shakti H. Ramkissoon
    Lee A. Albacker
    Alice M. Walsh
    Communications Medicine, 1
  • [3] Assessment of the tumor mutational burden in a large cohort of Chinese advanced pan-cancer patients
    Liu, Ping
    Cui, Longgang
    Cai, Shangli
    CANCER RESEARCH, 2020, 80 (16)
  • [4] Pan-cancer landscape of clonal tumor mutational burden (cTMB)
    Parikh, A. R.
    Murugesan, K.
    Hopkins, J. F.
    Arshad, Z.
    Jin, D. X.
    Klempner, S. J.
    Fabrizio, D. A.
    Frampton, G. M.
    He, J.
    Montesion, M.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S582 - S583
  • [5] Pan-Cancer assessment of tumor mutational burden using a comprehensive genomic profiling assay.
    Nichol, Donna
    Jones, Sian
    Angiouli, Samuel V.
    Keefer, Laurel
    Nesselbush, Monica
    Sengamalay, Naomi
    White, James
    Simmons, John
    Diaz, Luis A.
    Velculescu, Victor E.
    Sausen, Mark
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [6] Analytic validation of a pan-cancer tumor mutational burden assay
    Nesselbush, Monica
    Jones, Sian
    Keefer, Laurel
    Sengamalay, Naomi
    Velculescu, Victor
    Diaz, Luis
    Sausen, Mark
    Angiuoli, Samuel
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [7] Real-world pan-cancer landscape of frameshift mutations and their role in predicting responses to immune checkpoint inhibitors in cancers with low tumor mutational burden
    Florou, Vaia
    Floudas, Charalampos S.
    Maoz, Asaf
    Naqash, Abdul Rafeh
    Norton, Carter
    Tan, Aik Choon
    Sokol, Ethan S.
    Frampton, Garrett
    Soares, Heloisa P.
    Puri, Sonam
    Swami, Umang
    Wilky, Breelyn
    Hosein, Peter
    Trent, Jonathan
    Lopes, Gilberto de Lima
    Park, Wungki
    Garrido-Laguna, Ignacio
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (08)
  • [8] Clinical and utilization outcomes associated with tumor mutational burden in a real-world pan-tumor population
    Gautam, Santosh
    Kachroo, Sumesh
    DeClue, Richard W.
    Fisher, Maxine D.
    Basu, Anirban
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2021, 10 (10) : 857 - 868
  • [9] Real-time data quality assurance analysis for real-world, pan-cancer data.
    Brown, Samantha
    Lee, Jasme
    Pillai, Anjali
    Gandhi, Fenil
    Bahadur, Nadia
    Barton, Laura
    Chan, Kimberly
    Niederhausern, Andrew
    Nichols, Chelsea
    Philip, John
    Regazzi, Ashley Marie
    Shah, Neil J.
    Panageas, Katherine
    Lavery, Jessica A.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [10] Tumor mutational and indel burden: a systematic pan-cancer evaluation as prognostic biomarkers
    Wu, Hao-Xiang
    Wang, Zi-Xian
    Zhao, Qi
    Chen, Dong-Liang
    He, Ming-Ming
    Yang, Lu-Ping
    Wang, Ying-Nan
    Jin, Ying
    Ren, Chao
    Luo, Hui-Yan
    Wang, Zhi-Qiang
    Wang, Feng
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (22)
12345